Tech Company Financing Transactions
Validose Funding Round
Private investors participated in a $2 million Seed venture round for Validose. The round was recorded on 2/20/2025.
Transaction Overview
Company Name
Announced On
2/20/2025
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Seed
Investors
private investors (Lead Investor) (Peter Bauer)
Proceeds Purpose
The company intends to use the funds to finalize the development of its ophthalmic solution, a smart-dose eye-dropper, which will be launched in Q2 2025.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
63 Flushing Ave, Building 303 809
Brooklyn, NY 11205
USA
Brooklyn, NY 11205
USA
Phone
Website
Email Address
Overview
Validose solves patient non-adherence by enabling real-time action from precise insights to drive patient behavior, streamline decision-making, and enhance health outcomes. Validose is transforming clinical trial success with our groundbreaking smart-dose technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul McGrath
Browse more venture capital transactions:
Prev: 2/20/2025: Zymvol Biomodeling venture capital transaction
Next: 2/20/2025: Arize AI venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs